Arbutin blocks defects in the ripple phase of DMPC bilayers by changing carbonyl organization

Chem Phys Lipids. 2007 May;147(1):22-9. doi: 10.1016/j.chemphyslip.2007.03.003. Epub 2007 Mar 19.

Abstract

The effect of arbutin, a 4-hydroxyphenyl-beta-glucopyranoside, on dimyristoylphosphatidylcholine (DMPC) bilayers was studied by turbidimetry, EPR and FTIR spectroscopies. The disruption of DMPC multilamellar vesicles (MLV's) with monomyristoylphosphatidylcholine (lysoPC), a product of hydrolysis of phospholipase A(2) (PLA(2)), is more efficient at 18 degrees C, where DMPC MLV's are known to be in the ripple P(beta') phase, than at 10 degrees C (L(beta') flat gel phase). Disruption at 18 degrees C was inhibited by increasing concentrations of arbutin in the solution. This inhibition was correlated with the disappearance of the ripple phase in MLV's when arbutin is present. Shifts in FTIR carbonyl bands caused by arbutin or by temperature changes allow us to propose a model. It is interpreted that the changes in the water-hydrocarbon interface caused by arbutin, forcing a reaccommodation of the carbonyl groups, eliminate the topological defects in the lattice due to mismatches among regions with different area per lipid where lysoPC can insert.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arbutin / pharmacology*
  • Dimyristoylphosphatidylcholine / chemistry*
  • Electron Spin Resonance Spectroscopy
  • Lipid Bilayers*
  • Spectroscopy, Fourier Transform Infrared

Substances

  • Lipid Bilayers
  • Arbutin
  • Dimyristoylphosphatidylcholine